Clinical Trials Browser

Has results × Nevus, Sebaceous of Jadassohn × burosumab × Clear all

NCT02304367 2024-05-06

Study of Burosumab (KRN23) in Adults With Tumor-Induced Osteomalacia (TIO) or Epidermal Nevus Syndrome (ENS)

Phase 2 Completed

17 enrolled 66 charts

Oncogenic osteomalacia, Nevus, Sebaceous of Jadassohn

NCT04320316 2022-10-07

ENS

Phase 4 Completed

1 enrolled 10 charts

Nevus, Sebaceous of Jadassohn